KOUSKY KENNETH W 4
4 · Gemphire Therapeutics Inc. · Filed Jan 30, 2018
Insider Transaction Report
Form 4
KOUSKY KENNETH W
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-29+10,800→ 10,800 totalExercise: $10.44Exp: 2028-01-28→ Common Stock (10,800 underlying)
Footnotes (1)
- [F1]The option vests in a series of 12 successive equal monthly installments on the last day of each month, commencing on the grant date.